These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9354244)
21. Differential non-redox inhibitory effects of glutathione against protein kinase C isozyme family members. Ward NE; Fan G; O'Brian CA Oncol Rep; 1999; 6(2):307-10. PubMed ID: 10022994 [TBL] [Abstract][Full Text] [Related]
22. Isoform-selectivity of PKC inhibitors acting at the regulatory and catalytic domain of mammalian PKC-alpha, -betaI, -delta, -eta and -zeta. Saraiva L; Fresco P; Pinto E; Gonçalves J J Enzyme Inhib Med Chem; 2003 Dec; 18(6):475-83. PubMed ID: 15008511 [TBL] [Abstract][Full Text] [Related]
23. Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC). Zimmermann J; Caravatti G; Mett H; Meyer T; Müller M; Lydon NB; Fabbro D Arch Pharm (Weinheim); 1996 Jul; 329(7):371-6. PubMed ID: 8764886 [TBL] [Abstract][Full Text] [Related]
24. UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily. Mizuno K; Noda K; Ueda Y; Hanaki H; Saido TC; Ikuta T; Kuroki T; Tamaoki T; Hirai S; Osada S FEBS Lett; 1995 Feb; 359(2-3):259-61. PubMed ID: 7867810 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties. Xu Y; Stenmark KR; Das M; Walchak SJ; Ruff LJ; Dempsey EC Am J Physiol; 1997 Jul; 273(1 Pt 1):L234-45. PubMed ID: 9252561 [TBL] [Abstract][Full Text] [Related]
26. TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes. O'Connell MA; Kelleher D; Liskamp RM; Hall N; O'Neill LA; Long A Cytokine; 1997 Feb; 9(2):83-92. PubMed ID: 9071558 [TBL] [Abstract][Full Text] [Related]
28. Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Ward NE; Stewart JR; Ioannides CG; O'Brian CA Biochemistry; 2000 Aug; 39(33):10319-29. PubMed ID: 10956021 [TBL] [Abstract][Full Text] [Related]
29. Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Stewart JR; O'Brian CA Invest New Drugs; 2004 Apr; 22(2):107-17. PubMed ID: 14739659 [TBL] [Abstract][Full Text] [Related]
30. Novel protein kinase C inhibitors: synthesis and PKC inhibition of beta-substituted polythiophene derivatives. Xu WC; Zhou Q; Ashendel CL; Chang CT; Chang CJ Bioorg Med Chem Lett; 1999 Aug; 9(15):2279-82. PubMed ID: 10465561 [TBL] [Abstract][Full Text] [Related]
31. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells. Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804 [TBL] [Abstract][Full Text] [Related]
32. Characterization of phorbol ester binding to protein kinase C isotypes. Dimitrijević SM; Ryves WJ; Parker PJ; Evans FJ Mol Pharmacol; 1995 Aug; 48(2):259-67. PubMed ID: 7651359 [TBL] [Abstract][Full Text] [Related]
33. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Kellerer M; Mushack J; Seffer E; Mischak H; Ullrich A; Häring HU Diabetologia; 1998 Jul; 41(7):833-8. PubMed ID: 9686926 [TBL] [Abstract][Full Text] [Related]
34. Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues. Jones T; Courage C; Hubbard A; Gescher A Biochem Pharmacol; 1997 May; 53(10):1413-8. PubMed ID: 9260867 [TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. Chen CC; Wang JK; Lin SB J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107 [TBL] [Abstract][Full Text] [Related]
36. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Geiges D; Meyer T; Marte B; Vanek M; Weissgerber G; Stabel S; Pfeilschifter J; Fabbro D; Huwiler A Biochem Pharmacol; 1997 Mar; 53(6):865-75. PubMed ID: 9113106 [TBL] [Abstract][Full Text] [Related]
37. PKC isozyme S-cysteinylation by cystine stimulates the pro-apoptotic isozyme PKC delta and inactivates the oncogenic isozyme PKC epsilon. Chu F; Ward NE; O'Brian CA Carcinogenesis; 2003 Feb; 24(2):317-25. PubMed ID: 12584183 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of protein kinase C by resveratrol. Slater SJ; Seiz JL; Cook AC; Stagliano BA; Buzas CJ Biochim Biophys Acta; 2003 Jan; 1637(1):59-69. PubMed ID: 12527408 [TBL] [Abstract][Full Text] [Related]
39. PKC regulation of the human equilibrative nucleoside transporter, hENT1. Coe I; Zhang Y; McKenzie T; Naydenova Z FEBS Lett; 2002 Apr; 517(1-3):201-5. PubMed ID: 12062437 [TBL] [Abstract][Full Text] [Related]
40. Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters. Wang XJ; Warren BS; Rupp T; Beltrán LM; DiGiovanni J Carcinogenesis; 1994 Dec; 15(12):2795-803. PubMed ID: 8001237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]